Sen-Jam's COVID Therapeutic Receives Final Approval from NHRC to Commence their Clinical Trial in Partnership with Duke University School of Medicine | Sen-Jam Pharmaceutical

https://wefunder.com/feed/152893

Published at: 2022-02-20 16:31:43 UTC

Author: Jim Iversen

Subject: Sen-Jam Pharmaceutical

This past Friday at 5:19am, Sen-Jam Pharmaceutical in partnership with Duke University School of Medicine received full approval from the Nepal Health Research Committee to begin dosing for (SJP-oo2C); a promising COVID-19 therapeutic embarking on...